Rifampin, in addition to interfering with intracellular growth of the ribonucleic acid-containing phage MS2, also inhibits the release of mature phage particles from Escherichia coli cells.
The antibiotic rifampin blocks ribonucleic acid (RNA) synthesis in Escherichia coli (5-7) by acting on the core of the enzyme deoxyribonucleic acid (DNA)-dependent RNA polymerase (4, 9, 10) . It was reported that this drug also inhibits RNA phage development in E. coli when applied prior to or within a few minutes after infection (5, 8) , whereas its addition 5 min after infection permitted near normal growth of RNA phage (5) . No effect on RNA phage development was detected when a mutant of E. coli possessing a rifampin-resistant DNA-dependent RNA polymerase was used as an host (8) , and it was suggested that host DNA-dependent RNA polymerase is involved in phage RNA replication either directly (5, 8) or indirectly (2).
Here we report that rifampin interferes not only with intracellular growth of the RNAcontaining phage MS2 but also inhibits the release of mature phage particles from E. coli cells.
A culture of E. coli AB301 (Hfr met X+), rifampin-sensitive, (kindly supplied by R. Gesteland) was grown with aeration at 37 C in tryptone broth medium (3) . Cells at a density of 2.108 ml were infected with MS2 phage at a multiplicity of infection of 10. Rifampin, at a final concentration of 100 ,ug ml, was added at various times postinfection Forty and 150 min after infection, the cultures were centrifuged at 10,000 rev/min for 20 min at 4 C. The supernatants were titrated (1) phage yield, samples of the cultures were withdrawn and lysed in the lysozyme-EDTA-chloroform solution as described above.
The effect of rifampin on extracellular, intracellular, and total phage yields is illustrated in Since it was previously reported that rifampin inhibits intracellular phage synthesis (5, 8) , the reduction in extracellular phage yield could be a result of low phage production. This seems most unlikely since the inhibitory effect of rifampin on extracellular phage yield could be completely separated from its effect on phage synthesis. In our experiments, phage synthesis was unaffected when the drug was applied 20 min or later postinfection. Even when the antibiotic was added at the time of infection, which reduced phage synthesis by a factor of 10, only 2.5%NO of the total phage yield was found in the extracellular medium ( Table 1) .
As demonstrated (Table 1) , the reduction of extracellular phage content in the presence of rifampin was accompanied by an equivalent intracellular accumulation of progeny phage particles. For example, when the drug was added at 20 min postinfection, only 12% of the extracellular phage content was obtained, whereas 90,'% of the total phage particles were intracellularly located. Therefore, the diminished extracellular phage represents an inhibition of phage release from the host.
These data indicate that rifampin, in addition to its known effect of interfering with RNA phage synthesis (5, 8) , also inhibits the release of progeny phage particles from the host cells. The release process itself may involve a step for which the host DNA-dependent RNA polymerase is required. This possibility is supported by the observation that MS2 plates normally on mutants possessing rifampin-resistant DNA-dependent RNA polymerase (8) . As a consequence, one may speculate that host-controlled protein(s) participate in the release of RNA phage particles from bacteria. This could be relevant to the mechanism of phage release.
